COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1652: Articles 16511-16520  | Next

Neurological manifestations of patients with mild-to-moderate COVID-19 attending a public hospital in Lima, Peru
Carcamo Garcia, M. H., Garcia Choza, D. D., Salazar Linares, B. J., Diaz, M. M.
10.1101/2021.03.16.21253736 — Posted: 2021-03-20
Effect of information about COVID-19 vaccine effectiveness and side effects on behavioural intentions: two online experiments
Kerr, J. R., Freeman, A. L. J., Marteau, T. M., van der Linden, S.
10.1101/2021.03.19.21253963 — Posted: 2021-03-20
Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian State of Karnataka
Pattabiraman, C., Prasad, P., George, A. K., Sreenivas, D., Rasheed, R., Reddy, N. V. K., Desai, A., Vasanthapuram, R.
10.1101/2021.03.17.21253810 — Posted: 2021-03-20
Modelling the impact of rapid tests, tracing and distancing in lower-income countries suggest optimal policies varies with rural-urban settings
Jiang, X., Gong, W., Gao, Y., Fraser, C., Holmes, C.
10.1101/2021.03.17.21253853 — Posted: 2021-03-20
Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study
Leidi, A., Koegler, F., Dumont, R., Dubos, R., Zaballa, M.-E., Piumatti, G., Coen, M., Berner, A., Darbellay Farhoumand, P., Vetter, P., Vuilleumier, N., Kaiser, L., Courvoisier, D., Azman, A., Guessous, I., Stringhini, S.
10.1101/2021.03.19.21253889 — Posted: 2021-03-20
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis
Hogan, A. B., Winskill, P., Watson, O. J., Walker, P. G. T., Whittaker, C., Baguelin, M., Brazeau, N. F., Charles, G. D., Gaythorpe, K. A. M., Hamlet, A., Knock, E., Laydon, D. J., Lees, J. A., Lochen, A., Verity, R., Whittles, L. K., Muhib, F., Hauck, K., Ferguson, N. M., Ghani, A. C.
10.1101/2021.03.19.21253960 — Posted: 2021-03-20
Factors Associated with Intention to Vaccinate against COVID-19 in Puerto Rico
Melin, K., Zhang, C., Zapata, J. P., Rivera, Y. M., Shacham, E., Malave-Rivera, S. M., Rodriguez-Diaz, C. E.
10.1101/2021.03.19.21253972 — Posted: 2021-03-20
Return to normal: COVID-19 vaccination under mitigation measures
Marziano, V., Guzzetta, G., Mammone, A., Riccardo, F., Poletti, P., Trentini, F., Manica, M., Siddu, A., Stefanelli, P., Pezzotti, P., Ajelli, M., Brusaferro, S., Rezza, G., Merler, S.
10.1101/2021.03.19.21253893 — Posted: 2021-03-20
Investigation of the ventilation situation in a lecture room of building 033 at the Universität der Bundeswehr München
Kähler, C. J., Fuchs, T., Hain, R.
10.1101/2021.03.17.21253800 — Posted: 2021-03-20
Modelling the population-level protection conferred by COVID-19 vaccination
Padmanabhan, P., Desikan, R., Dixit, N. M.
10.1101/2021.03.16.21253742 — Posted: 2021-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).